<?xml version="1.0" encoding="UTF-8"?>
<list list-type="bullet">
 <list-item>
  <p>1,674,000 TB deaths, of which 374,000 were in HIV co-infected persons (“the ninth leading cause of death worldwide and the leading cause from a single infectious agent, ranking above HIV/AIDS” 
   <sup>
    <xref rid="ref-1" ref-type="bibr">1</xref>
   </sup>); 374,000 of these deaths occurring in HIV-infected persons
  </p>
 </list-item>
 <list-item>
  <p>10.4 million cases of TB disease, 56% of which were in 5 countries: India, Indonesia, China, the Philippines and Pakistan;</p>
 </list-item>
 <list-item>
  <p>600,000 cases of rifampicin-resistant TB (RR-TB), of which 490,000 were multidrug-resistant TB (MDR-TB). Globally, an estimated 4.1% of new cases and 19% of previously treated cases had MDR or RR-TB, with 47% of the global total of drug-resistant cases reported from China, India and the Russian Federation. 250,000 of these 490,000 died.</p>
 </list-item>
 <list-item>
  <p>A U.S. $2.3 billion funding gap for financing TB care and prevention existed in 2017</p>
 </list-item>
</list>
